Literature DB >> 17485770

Do newer prescription drugs pay for themselves? A reassessment of the evidence.

Yuting Zhang1, Stephen B Soumerai.   

Abstract

Citing evidence from studies conducted by Frank Lichtenberg, some health policy advocates have argued that, on average, use of new prescription drugs reduces total health care costs. While recognizing that the cross-sectional research design cannot guard against many biases that could overstate the results, we replicated the original study results and examined the findings' sensitivity to different analytical approaches. Using the same data, we were able to replicate the original results; however, the original findings are not maintained under plausible alternative assumptions. More rigorous research on specific drugs and conditions is necessary before one can claim that newer drugs lower total health care costs.

Mesh:

Year:  2007        PMID: 17485770     DOI: 10.1377/hlthaff.26.3.880

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  12 in total

1.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

2.  Impact of new drugs and biologics on colorectal cancer treatment and costs.

Authors:  Pinar Karaca-Mandic; Jeffrey S McCullough; Mustaqeem A Siddiqui; Holly Van Houten; Nilay D Shah
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

Review 3.  Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to Greece.

Authors:  E Karampli; K Souliotis; N Polyzos; J Kyriopoulos; E Chatzaki
Journal:  Hippokratia       Date:  2014-04       Impact factor: 0.471

4.  Health services use and prescription access among uninsured patients managing chronic diseases.

Authors:  Jewel Goodman Shepherd; Elizabeth Locke; Qi Zhang; George Maihafer
Journal:  J Community Health       Date:  2014-06

5.  Enhancing prescription drug innovation and adoption.

Authors:  G Caleb Alexander; Alec B O'Connor; Randall S Stafford
Journal:  Ann Intern Med       Date:  2011-06-21       Impact factor: 25.391

6.  A Welfare Measure of "Offset Effects" in Health Insurance.

Authors:  Jacob Glazer; Thomas G McGuire
Journal:  J Public Econ       Date:  2012-02-25

7.  Do new drugs increase life expectancy? A critique of a Manhattan Institute paper.

Authors:  Dean Baker; Adriane Fugh-Berman
Journal:  J Gen Intern Med       Date:  2009-03-24       Impact factor: 5.128

8.  The role of preclinical animal models in breast cancer drug development.

Authors:  Robert Clarke
Journal:  Breast Cancer Res       Date:  2009-12-18       Impact factor: 6.466

9.  Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice.

Authors:  Ana Lozano-Blázquez; Cecilia Calvo-Pita; Mónica Carbajales-Álvarez; Patricio Suárez-Gil; Fernando Martínez-Martínez; Miguel Ángel Calleja-Hernández
Journal:  Ther Clin Risk Manag       Date:  2014-07-09       Impact factor: 2.423

10.  Public research funding and pharmaceutical prices: do Americans pay twice for drugs?

Authors:  Rena M Conti; Frank S David
Journal:  F1000Res       Date:  2020-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.